Invanz, Lyophilisat zur Herstellung einer Infusionslösung

7680559020037 CH-55902 Lyophilisat

Associated product:

INVANZ subst sèche 1 g flac
Invanz, Lyophilisat zur Herstellung einer Infusionslösung
Invanz, Lyophilisat zur Herstellung einer Infusionslösung
Invanz, Lyophilisat zur Herstellung einer Infusionslösung
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Lyophilisat
Galenic group
Lösbar zur Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
20/08/2025
Summary of Product Characteristics
Français
20/08/2025
Summary of Product Characteristics
Italien
20/08/2025

Detailed composition

Substance Quantity Type Category
(N/A)
1.0 G Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI

Reimbursement information

Public price
CHF 68.80
Specialties list
Yes
Generic
No
SL addition date: 01/01/2007

Authorization holder

MSD Merck Sharp & Dohme AG

6005 Luzern

Authorization information

Swissmedic authorization number
55902
Drug name
Invanz, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Galenic form
PULPI
ATC Code
J01DH03
Authorization status
Z
Dispensing category
A
First authorization
19/06/2003
Authorization expiration date
31/12/9999
IT Number
08.01.25
Domain
Human medicine
Field of application
Infektionskrankheiten

Package details

Description (FR)
INVANZ subst seche 1 g 1 pce
Description (DE)
INVANZ Trockensub 1 g 1 Stk
Market launch
19/06/2003
Narcotic (BTM)
No

Other package sizes (2)

None
None None
GTIN: None
Not in V1
INVANZ subst sèche 1 g (ancien) flac 10 pce
None None
GTIN: 7680559020020
Not in V1